Skip to main content
letter
. 2020 Nov 19;121(1):98–101. doi: 10.1055/s-0040-1721317

Table 1. Course of blood coagulation and inflammation markers and in-hospital outcome in 577 patients with COVID-19.

Available Total
( N  = 577)
Survivors
( N  = 433)
Nonsurvivors
( N  = 144)
p -Value a
Men, n (%) 577/577 386 (67) 290 (67) 96 (67) 0.9
Age, y 577/577 67 (56, 77) 62 (52, 71) 77 (72, 85) <0.001
Intensive care unit, n (%) 576/577 98 (17) 72 (17) 26 (18) 0.8
D-Dimer
 At baseline, ng/mL 491/553 b 435 (268, 864) 375 (242, 681) 814 (386, 2230) <0.001
 Highest, ng/mL 553/553 b 872 (386, 2,456) 772 (341, 1,860) 1844 (678, 4,988) <0.001
 Lowest to highest increase, ng/mL per day 381/399 c 79 (21, 249) 69 (21, 200) 150 (13, 814) 0.017
 Latest to highest increase, ng/mL per day 381/399 c 88 (17, 391) 74 (18, 297) 185 (12, 1,088) 0.033
C-Reactive protein
 At baseline, mg/dL 553/574 b 8 (3, 15) 7 (3, 13) 13 (7, 21) <0.001
 Highest, mg/dL 574/574 b 15 (7, 24) 13 (6, 21) 22 (15, 30) <0.001
 Lowest to highest increase, mg/dL per day 398/406 c 2.0 (1.0, 3.7) 1.8 (0.9, 3.3) 2.9 (1.7, 4.9) <0.001
 Latest to highest increase, mg/dL per day 398/406 c 1.9 (0.8, 4.6) 1.7 (0.7, 3.8) 3.1 (1.4, 6.0) <0.001

Note: All continuous values (age in years and biomarker concentrations in ng/mL or mg/dL) are reported as median (interquartile range). Lowest to highest increase is defined as the average daily increase from the lowest measured value preceding the highest measured value to the highest value itself. Latest to highest increase is defined as the average daily increase from the last measured value before the highest measured value to the highest value itself.

a

Chi-square test for categorical variables and Wilcoxon rank-sum test for continuous variables.

b

Proportion out of all patients with at least one marker value available.

c

Proportion out of all patients in whom a slope with zero or positive increase was calculable (at least two values available and the highest value was not the baseline value).